Dosage and usage of Sebetralstat-Ekterly
Sebetralstat-Ekterly is a drug specifically indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults and children 12 years of age and older. HAE is a genetic disorder caused by a deficiency or dysfunction of the C1 esterase inhibitory protein, in which patients experience severe swelling and pain during acute attacks. Therefore, timely and effective medication is crucial to relieve symptoms.

After an acute attack of HAE is diagnosed, the recommended initial dose is 600 mg, that is, 2 tablets of sebetrostat, taken orally. If the patient's symptoms do not improve significantly within 3 hours after taking the first dose, or the condition continues to worsen or relapse, a second dose of 600 mg (2 tablets) can be taken orally. The maximum dose for patients should not exceed 1200 mg within 24 hours to ensure safe and effective symptom control.
During the use of sebetrostat, patients should carefully follow the instructions for use. When taking the medicine, first carefully remove the sebetralstat tablets from the packaging. The specific operation is as follows: go through the half circle of the packaging cardboard, then flip the package and peel off the label on the back, and finally push the tablet through the aluminum foil and take it out. The entire process needs to be kept dry and clean to avoid contamination or damage to the medication.
When taking sebetrostat, patients must fully follow the doctor's instructions to ensure the accuracy and effectiveness of the medication. This means that patients should not take more or less than the frequency and dosage prescribed by their doctor, and strictly following the medication regimen is key to ensuring successful treatment. At the same time, patients should pay close attention to their own reactions during medication. If they find discomfort or poor efficacy of the medication, they should contact medical staff immediately to discuss whether the treatment plan needs to be adjusted.
Reference materials:https://www.ekterly.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)